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licenseYounger pregnant women have a higher risk of striae gravidarum, the
study saidStriae gravidarum (stretch marks) is a common connective
tissue disorder of pregnant women that often initiates as
erythematous streaks or violaceous lesions. Over time, these
marks become pale, atrophic, and lax, and skin elasticity is
ultimately reduced.1 The histology of striae gravidarum shows
a reorganization and diminution of the elastic fiber network of
skin, atrophy, a decrease in the thickness of the dermis, and
loss of rete ridges.2 Although striae gravidarum apparently
does not affect body function, it is considered to be a dis-
figuring lesion due to the permanent scar-like alteration in skin
appearance that can result in itching and discomfort. Fur-
thermore, it can place a significant psychological burden on
affected women.3,4
Little is known about its epidemiology. The estimated
prevalence of striae gravidarum ranges from 50% to 90% in
pregnant women, making this the most common cutaneous
complication of pregnancy and one of the most prevalent skin
complaints in affected individuals.5 Elastic fibers are complex,
multicomponent structures that imbue tissues with the ability
to resist forces in a controlled and measured way, ultimately
returning the tissue to its original anatomical position.5 A
recent publication in England showed a marked disruption of
the elastic fiber network and the emergence of newly synthe-
sized thin and disorganized tropoelastic-rich fibrils. This
contributed to an abnormal function of the elastic fibers in the
early stage of striae gravidarum, suggesting a significant
remodeling of the cutaneous elastic fiber system as a result of
the increased low-intensity load placed on the skin during
pregnancy.1 However, the key biological driver underlying this
remodeling is still unknown, contributing to the difficulty in
identifying the real causative mechanisms of striae grav-
idarum, which subsequently result in an unfavorable outcome
in any attempt to prevent the development of striae grav-
idarum; this includes the study by Ersoy et al6 in this issue of
the Journal of Chinese Medical Association.
The study by Ersoy et al6 investigated 211 pregnant women
attending Zekai Tahir Burak Women's Health Care Training and
Research Hospital, Altindag, Ankara, Turkey between August
2013 and October 2013. The results in this study showed that
80% of pregnant women with striae gravidarum had the
following identified situations, including a family history ofx.doi.org/10.1016/j.jcma.2016.01.003
901/Copyright © 2016, the Chinese Medical Association. Published by El
(http://creativecommons.org/licenses/by-nc-nd/4.0/).striae gravidarum: delivery of a male baby and a low education
level (primary school education or less).6 In addition, factors
such as younger age, a high prepregnancy body mass index, a
high postpregnancy body mass index, a large abdominal
circumference, a considerably large ratio of abdominal
circumference to length, and a high birth weight were associated
with an elevated risk of developing striae gravidarum.6However,
any treatment strategy that included oil, cream, and any
combination of both showed little effect on the prevention of
striae gravidarum, due to the absence of any statistically sig-
nificant difference between women who received and those who
did not receive such treatment.6 Therefore, the findings in Ersoy
et al's6 report were not surprising, since a recent Cochrane
Database of Systematic Review summarized the clinical data
comparing topical preparation (with active ingredients) with a
placebo. Those results showed no significant average difference
in the development of striae gravidarum in women who were
treated compared with those who were not treated [average risk
ratio 0.74, 95% confidence internal (CI) 0.53e1.03; 5 trials
enrolling a total of 474 women].4 The authors concluded that
there was little evidence to support the use of any topical
preparation in the prevention of striae gravidarum during preg-
nancy.4 Since prevention of striae gravidarum does not work,
how can we undertake therapies or treatments that fail to
recognize this? Therefore, identification of the potential risk
factors that may contribute to striae gravidarum may be an
alternative way to approach this problem.
By multivariate analysis, Ersoy et al6 found that only age
may be the most important factor for development of striae
gravidarum. Additionally, women who were considerably
younger might have a significantly elevated risk of developing
striae gravidarum (risk ratio 1.15, 95% CI 1.06e1.25,
p ¼ 0.001),6 suggesting that age might be one of the important
modifiable factors that can result in striae gravidarum. How-
ever, the authors' finding begs the question: what is the cutoff
age for women who are young enough to influence the
development of striae gravidarum? Unfortunately, the authors
failed to answer this question. The answer could, in fact, be
that younger women have considerably higher fragility in their
fibrillin, as explained by the authors.6 Finally, is this finding
consistent with previous studies?sevier Taiwan LLC. This is an open access article under the CC BY-NC-ND
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gravidarum” to search PubMed (http://www.ncbi.nlm.nih.gov/
pubmed), and a total of 57 published articles were identified.
It was interesting to discover that nearly all those articles
addressing risk factors for the development of striae gravidarum
were related to younger age, except for one study by Dr Davey7
in 1972. That is to say that it is credible that younger patient age
is a risk factor for striae gravidarum, which would provide a
reasonable response to the first question. One similar study from
France by Picard et al,3 which enrolled 800 consecutive pri-
migravida, might be a good reference to investigate the younger
age cutoff value as referenced above. For pregnant women
younger than 20 years (51women in the study group), more than
80%were complicated with striae gravidarum [43 (84.3%) vs. 8
(15/7%)].3 By contrast, the percentage was 78.8% in women
with striae gravidarum who were 20e24 years of age, 51.8% in
women 25e29 years of age, and 24.1% in women 30 years of
age. This contributed to an odds ratio of 24.61 (95% CI
9.96e60.77) for women younger than 20 years, 12.85 (95% CI
7.85e21.04) in women aged between 20 and 24 years, and 3.43
(95% CI 2.21e5.34) in women aged between 25 and 29 years,
compared for women aged 30 years.3 Therefore, the concept
that pregnancy in adolescents is associated with the risk of
developing striae gravidarum is worthy of our attention. In fact,
pregnant adolescents might not only increase the risk of these
permanent body image changes (occurrence of striae grav-
idarum), but also have the highest risk of increased perinatal
morbidity and mortality.8,9 Based on the above findings, this
reinforces the idea that global health is associated with the
sexual activity of adolescents, underscoring the often-neglected
need for appropriate contraception education and improved
steps to prepare these high-risk women who attempt to get
pregnant.10e12 Considerably more efforts should be undertaken
to minimize the possibility of unwanted and/or unplanned
pregnancy in adolescents.
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